cis-Platinum in advanced gynecologic malignancy

Frederick B. Stehman, Samuel C. Ballon, Leo D. Lagasse, Terry P. Chamorro, Robert C. Donaldson, James A. Roberts, Larry C. Ford

Research output: Contribution to journalArticle

8 Scopus citations

Abstract

Eighteen patients with advanced gynecologic malignancies received cis-diamminedichloroplatinum (NSC 119875), an inorganic heavy metal compound with antineoplastic properties. Twelve patients had carcinoma of the ovary resistant to other chemotherapeutic agents. Three patients had previously irradiated carcinoma of the cervix; two, disseminated pelvic sarcoma; and one, metastatic carcinoma of the vulva. Objective responses were achieved in four patients (25%) with carcinoma of the ovary. Three patients with other tumors also responded. Mild to severe myelosuppression, nephrotoxicity, and ototoxicity occurred.

Original languageEnglish (US)
Pages (from-to)349-360
Number of pages12
JournalGynecologic Oncology
Volume7
Issue number3
DOIs
StatePublished - Jun 1979
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Obstetrics and Gynecology

Fingerprint Dive into the research topics of 'cis-Platinum in advanced gynecologic malignancy'. Together they form a unique fingerprint.

  • Cite this

    Stehman, F. B., Ballon, S. C., Lagasse, L. D., Chamorro, T. P., Donaldson, R. C., Roberts, J. A., & Ford, L. C. (1979). cis-Platinum in advanced gynecologic malignancy. Gynecologic Oncology, 7(3), 349-360. https://doi.org/10.1016/0090-8258(79)90113-6